There are disclosed methods for prophylaxis or treatment of cancer in a mammal. The methods comprise administering an effective amount of an agent to the mammal, which 5 binds to a MAP kinase or an integrin such that binding of the MAP kinase to the integrin is inhibited. ERK2 (2.SuM) binding to blotinylated beta 210(4) (blotin KEKLKNPLFK) In solution before capture onto Immobiflsed streptavidin. Anti-Er2 detection. - 0.85 g 0.75 a;O0.65 cc 0.46 0 0.1 0.2 0.5 1 beta 2 10(4) (bIotIn-KEKLKNPLFK) concntMon - uM @ - --"I 6- ; -cy-b8 Erk2 psp 7-+-cy p38 pep7+cy JNRpep7+y Protein/peptide combinatfoN